0001209191-20-044548.txt : 20200803
0001209191-20-044548.hdr.sgml : 20200803
20200803183436
ACCESSION NUMBER: 0001209191-20-044548
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200801
FILED AS OF DATE: 20200803
DATE AS OF CHANGE: 20200803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eichenfield Lawrence
CENTRAL INDEX KEY: 0001814892
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38529
FILM NUMBER: 201070537
MAIL ADDRESS:
STREET 1: C/O FORTE BIOSCIENCES, INC.
STREET 2: 1124 W. CARSON ST., MRL BLDG 3-320
CITY: TORRANCE
STATE: CA
ZIP: 90502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verrica Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001660334
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463137900
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 NORTH HIGH STREET
STREET 2: SUITE 200
CITY: WEST CHESTER
STATE: PA
ZIP: 19380
BUSINESS PHONE: 484-453-3300
MAIL ADDRESS:
STREET 1: 10 NORTH HIGH STREET
STREET 2: SUITE 200
CITY: WEST CHESTER
STATE: PA
ZIP: 19380
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-01
0
0001660334
Verrica Pharmaceuticals Inc.
VRCA
0001814892
Eichenfield Lawrence
C/O VERRICA PHARMACEUTICALS INC.
10 NORTH HIGH STREET, SUITE 200
WEST CHESTER
PA
19380
1
0
0
0
Stock Option (right to buy)
6.56
2020-08-01
4
A
0
17502
0.00
A
2030-07-31
Common Stock
17502
17502
D
1/3rd of the total shares subject to the option shall vest on August 1, 2021 and 1/36th of the total shares subject to the option shall
vest monthly thereafter over the remaining two years of the vesting period, subject to the Reporting Person's continuous service through such
vesting date.
/s/ Mark Ballantyne, Attorney-in-Fact
2020-08-03